A Clinical Adverse Drug Reaction Prediction Model for Patients with Chagas Disease Treated with Benznidazole

Benznidazole (BZN) is the main trypanocidal drug used to treat Chagas disease, and the evidence supporting the benefits of BZN use during the chronic phase of the disease will favor its use in millions of individuals. However, more than 30% of patients treated with BZN may suffer adverse drug reacti...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Sperandio da Silva, Gilberto Marcelo, Mediano, Mauro Felippe Felix, Alvarenga Americano do Brasil, Pedro Emmanuel, da Costa Chambela, Mayara, da Silva, Joyce Almeida, de Sousa, Andrea Silvestre, Xavier, Sergio Salles, Rodrigues da Costa, Andrea, Magalhães Saraiva, Roberto, Hasslocher-Moreno, Alejandro Marcel
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2014
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249401/
https://ncbi.nlm.nih.gov/pubmed/25114135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02842-14
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires